X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ovarian cancer (34) 34
index medicus (32) 32
oncology (30) 30
female (29) 29
humans (29) 29
aged (23) 23
middle aged (22) 22
adult (21) 21
chemotherapy (20) 20
ovarian neoplasms - drug therapy (18) 18
cancer (16) 16
aged, 80 and over (12) 12
tumors (12) 12
antineoplastic agents - therapeutic use (11) 11
article (11) 11
disease-free survival (11) 11
ovarian neoplasms - pathology (11) 11
mutation (10) 10
neoplasm recurrence, local - drug therapy (10) 10
antineoplastic agents - adverse effects (9) 9
care and treatment (9) 9
bevacizumab (8) 8
male (8) 8
open-label (8) 8
treatment outcome (8) 8
hematology, oncology and palliative medicine (7) 7
olaparib (7) 7
ovarian neoplasms - genetics (7) 7
poly polymerase (7) 7
research (7) 7
abridged index medicus (6) 6
analysis (6) 6
breast cancer (6) 6
breast-cancer (6) 6
cancer therapies (6) 6
health aspects (6) 6
patients (6) 6
survival (6) 6
therapy (6) 6
young adult (6) 6
antineoplastic agents - administration & dosage (5) 5
carcinoma (5) 5
fallopian-tube (5) 5
immunology (5) 5
negative breast-cancer (5) 5
neoplasm staging (5) 5
ovarian neoplasms - mortality (5) 5
paclitaxel - administration & dosage (5) 5
platinum (5) 5
relapse (5) 5
trial (5) 5
womens health (5) 5
carboplatin (4) 4
cytotoxicity (4) 4
diseases (4) 4
endocrine system diseases (4) 4
germ-line mutation (4) 4
kaplan-meier estimate (4) 4
mortality (4) 4
neoplasms - drug therapy (4) 4
neoplasms. tumors. oncology. including cancer and carcinogens (4) 4
obstetrics & gynecology (4) 4
ovarian carcinoma (4) 4
phase-ii trial (4) 4
phthalazines - adverse effects (4) 4
phthalazines - therapeutic use (4) 4
piperazines - adverse effects (4) 4
piperazines - therapeutic use (4) 4
prospective studies (4) 4
women (4) 4
allergy (3) 3
allergy and immunology (3) 3
animals (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antibody-drug conjugate (3) 3
antimitotic agents (3) 3
antineoplastic agents (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
apoptosis (3) 3
biomarkers, tumor - genetics (3) 3
brca1 protein - genetics (3) 3
brca2 protein - genetics (3) 3
cervical cancer (3) 3
clinical trials (3) 3
combination (3) 3
death (3) 3
desensitization, immunologic - methods (3) 3
diagnosis (3) 3
dose-response relationship, drug (3) 3
double-blind method (3) 3
drug administration schedule (3) 3
drug hypersensitivity - therapy (3) 3
drug therapy (3) 3
expression (3) 3
fallopian tube neoplasms - drug therapy (3) 3
genes, brca1 (3) 3
homologous recombination (3) 3
intensive care (3) 3
maintenance chemotherapy (3) 3
maximum tolerated dose (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1579 - 1589
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 8, pp. 852 - 861
Journal Article
Lancet, The, ISSN 0140-6736, 2010, Volume 376, Issue 9737, pp. 245 - 251
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 12/2018, Volume 32, Issue 6, pp. xiii - xiv
Journal Article
Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 2016, Volume 4, Issue 3, pp. 497 - 504
Journal Article
Hematology/Oncology Clinics of North America, ISSN 0889-8588, 12/2018, Volume 32, Issue 6, pp. 997 - 1010
Large-scale genomic studies have demonstrated that ovarian cancer is characterized by frequent genetic and epigenetic alterations of gene members of the... 
Platinum agents | Homologous recombination deficiency | DNA repair deficiency | PARP-inhibitors | Ovarian cancer | BRCA2 MUTATIONS | HYPERMETHYLATION | COMBINATION | SOMATIC MUTATIONS | GEMCITABINE | PARP INHIBITOR | WOMEN | OLAPARIB | ONCOLOGY | HEMATOLOGY | CARCINOMA | ASSOCIATION
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1207 - 1214
Summary Background Olaparib is a poly(ADP-ribose) polymerase inhibitor and cediranib is an anti-angiogenic agent with activity against VEGF receptor (VEGFR) 1,... 
Hematology, Oncology and Palliative Medicine | TRIAL | POLY(ADP-RIBOSE) POLYMERASE | ONCOLOGY | BEVACIZUMAB | DOWN-REGULATION | FALLOPIAN-TUBE | OPEN-LABEL | EPITHELIAL OVARIAN | MAINTENANCE THERAPY | PRIMARY PERITONEAL | NEGATIVE BREAST-CANCER | Piperazines - administration & dosage | Confidence Intervals | Follow-Up Studies | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Cisplatin - administration & dosage | Dose-Response Relationship, Drug | Neoplasm Recurrence, Local - pathology | Neoplasms, Glandular and Epithelial - mortality | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Ovarian Neoplasms - drug therapy | Neoplasms, Glandular and Epithelial - pathology | Phthalazines - administration & dosage | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Treatment Outcome | Disease-Free Survival | Maximum Tolerated Dose | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Glandular and Epithelial - drug therapy | Survival Analysis | Carcinoma, Ovarian Epithelial | Aged | Women | Antimitotic agents | Relapse | Oncology, Experimental | Research | Antineoplastic agents | Vascular endothelial growth factor | Sugars | Cancer | Diseases | Monosaccharides | Ovarian cancer
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 137, Issue 4, pp. 1154 - 1164.e12
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2006, Volume 24, Issue 26, pp. 4324 - 4332
Journal Article
Nature communications, ISSN 2041-1723, 02/2018, Volume 9, Issue 1, pp. 628 - 1
The original version of this Article contained an error in the spelling of the author Yingjie Yu, which was incorrectly given as Yu Yingjie. Furthermore, in... 
Nanoparticles | Ovarian carcinoma | Platinum | Ovarian cancer | Cancer
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 03/2018, Volume 148, Issue 3, pp. 585 - 590
The Precision Medicine Initiative is a National Cancer Institute (NCI) driven interdisciplinary collaborative effort to test the feasibility of trials... 
NCI-MATCH | Precision medicine | Personalized medicine | Genomics
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2016, Volume 375, Issue 22, pp. 2154 - 2164
Journal Article
Science, ISSN 0036-8075, 11/2011, Volume 334, Issue 6059, pp. 1129 - 1133
Journal Article